PhD Position in Pharmaceutical Technology: A PhD position is available in the research group of Prof. Luciani at the University of Bern, focusing on “In vitro models of fibrosis in endometriosis as a screening tool for novel and repurposed drug candidates.” The program aims to explore therapeutic options for endometriosis, affecting a significant number of women globally.
Designation
PhD Student in Pharmaceutical Technology
| Detail | Information |
|---|---|
| Research Group | Prof. Luciani, University of Bern |
| Start Date | August 1, 2025 |
| Duration | 3-4 years |
Research Area
Endometriosis and fibrotic conditions, specifically developing 3D culture models to evaluate antifibrotic drugs.
Location
University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland
Eligibility/Qualification
- Master’s degree in Pharmaceutical Sciences or Pharmacy
- Previous experience with cell culture techniques
- Strong collaborative skills for interdisciplinary research
- Proactive and motivated with an interest in new technologies
- Fluent in English
- Willingness to teach and mentor undergraduate students
Description
The doctoral student will engage in developing three-dimensional culture models for fibrosis in endometriosis. This role includes evaluating potential antifibrotic drugs for endometriosis therapy, involving biomaterials, additive manufacturing, cell culture techniques, extracellular vesicles, and omics technologies. The student will be part of a multidisciplinary environment, collaborating closely with preclinical and clinical laboratories.
How to Apply
Interested candidates should send their applications via email to paola.luciani@unibe.ch by April 30, 2025. Applications must include:
- A motivation statement
- Curriculum Vitae (CV)
- A copy of the Master’s degree
- Two reference letters
All documents must be sent as a SINGLE PDF file. Applications that do not follow this guideline will not be considered.
Last Date to Apply
April 30, 2025
For further inquiries regarding the position, contact Prof. Dr. Paola Luciani at the provided email.
